Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.77 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.60%. A quarter ago, it was expected that this consumer products maker would post earnings of $0.82 per share when it actually produced earnings of $0.86, delivering a surprise of 4.88%.Over the last four quarters ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________ FORM 10-Q ________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to________ . Commission File Number: 1-644 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as spe ...

COLGATE-PALMOLIVE COMPANY 2Q 2024 EARNINGS PRESENTATION JULY 26, 2024 July 2024 Notice for Investor Presentation Please review the following second quarter 2024 earnings presentation in conjunction with our second quarter 2024 earnings press release, our second quarter 2024 prepared management remarks, our second quarter 2024 Quarterly Report on Form 10-Q and additional information regarding our non-GAAP financial measures, including GAAP to non-GAAP reconciliations, which are available in the Investor Cent ...

Exhibit 99 Colgate Announces 2nd Quarter 2024 Results • Net sales increased 4.9%; Organic sales* increased 9.0% • GAAP EPS increased 48% to $0.89; Base Business EPS* increased 18% to $0.91 • GAAP Gross profit margin increased 280 basis points to 60.6%; Base Business Gross profit margin* increased 300 basis points to 60.8% • Net cash provided by operations was $1,671 million for the first six months of 2024 • Colgate's leadership in toothpaste continued with its global market share at 41.5% year to date • Co ...

Colgate-Palmolive Company (CL) is expected to register top and bottom-line growth when it reports its second-quarter 2024 numbers on Jul 26, before the opening bell. The Zacks Consensus Estimate for second-quarter revenues is pegged at $5 billion, indicating a rise of 4.1% from the year-ago quarter’s reported figure.The consensus estimate for the company’s earnings is pegged at 87 cents per share, suggesting growth of 13% from the year-ago quarter’s reported figure. The Zacks Consensus Estimate for earnings ...

Colgate-Palmolive (CL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on July 26, 2024, might help the stock move higher if these key numbers are better than e ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the tr ...

Colgate-Palmolive Company (CL) stock is in investors’ good books, thanks to its robust business strategies. The pricing and productivity initiatives have been driving the company’s performance for a while now. Its innovation strategy and shareholder-friendly moves also bode well.Shares of this renowned consumer goods company have gained 31.9% in the past year compared with the industry’s 15.8% growth.Let’s Find Out MoreColgate has been gaining from strong pricing and the benefits of funding-the-growth progr ...

Bet_Noire/iStock via Getty Images Introduction Colgate-Palmolive (NYSE:CL) is set to announce Q2 earnings at the end of this month and there are three things that we are looking for in the report. Firstly, we would like to see continued improvement in the asset turnover ratio. An improvement in the ratio speaks to the strength of the brands and supports the continued investment in brand equity. Second, we would like to see improvement in margins, particularly in the Hill's Pet Nutrition segment. While s ...

Core Viewpoint - Certain dividend stocks can significantly hinder a portfolio's ability to generate sufficient cash flow for retirement, emphasizing the importance of selecting the right investments for passive income growth [3]. Investment Strategy - The concept of passive income is discussed, highlighting that even active investing can lead to passive income through initial research and selection efforts [4]. - The article argues that all investing ultimately aims for passive income, where money works for the investor rather than the other way around [4]. Dividend Growth Analysis - UnitedHealth Group (UNH) is presented as a strong investment option, currently yielding 1.75% with a 14% compound annual growth rate (CAGR) in dividends over the past decade. Projections suggest that a $10K investment could yield $645 annually in 10 years and $2,777 in 20 years if dividends are reinvested [5]. - Omega Healthcare Investors (OHI) offers a higher yield of 8%, with projections indicating $1,619 in annual dividends in 10 years and $3,515 in 20 years from a $10K investment, even without expected dividend growth [6]. Dividend Aristocrats Concerns - Dividend Aristocrats, while historically reliable, may not always be good investments due to the challenges of sustaining high dividend growth rates as companies mature. This can lead to unsustainable dividend increases [7]. - Examples of companies that have cut dividends include Walgreens Boots Alliance (WBA), 3M (MMM), and Leggett & Platt (LEG), demonstrating the risks associated with relying on Dividend Aristocrats for consistent income [8]. Specific Poor Dividend Investments - Colgate (CL) is identified as a poor investment due to its low yield of less than 2.2% and a historical average dividend growth of only 3% CAGR. Projections indicate only $342 in annual dividends in 10 years from a $10K investment [11][12]. - Johnson & Johnson (JNJ) is criticized for its declining dividend growth rates, with projections suggesting only $639 in annual dividends in 10 years from a $10K investment, which is below desirable income growth expectations [13][16]. - Walmart (WMT) is deemed unattractive due to its low yield of 1.2% and a high price-to-earnings ratio, with projections indicating only $300 in annual dividends in 10 years from a $10K investment, which is considered unsatisfactory [17][18]. Conclusion - The article concludes that while dividends can be beneficial for retirement income, investors must remain objective and rational in their stock selections to avoid overvalued or low-growth investments that could undermine their passive income goals [19].